GRI Bio Free Cash Flow (FCF) History (GRI)
GRI Bio reported −$10.2M in free cash flow for fiscal 2025, a decrease of $1.6M from the previous fiscal year.
View full GRI Bio company overviewGRI Bio free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$10.2M | −$1.6M | — | — |
| 2024 | 2024-12-31 | −$8.6M | $387,000 | — | — |
| 2023 | 2023-12-31 | −$9.0M | −$7.9M | — | — |
| 2022 | 2022-12-31 | −$1.1M | $7.2M | — | — |
| 2021 | 2021-12-31 | −$8.3M | −$4.6M | — | — |
| 2020 | 2020-12-31 | −$3.7M | — | — | −3708.00% |
GRI Bio quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$2.3M | −$957,000 | — | — |
| Q3 2023 | 2023-09-30 | −$1.3M | −$1.2M | — | — |
| Q3 2022 | 2022-09-30 | −$125,000 | $1.2M | — | — |
| Q3 2021 | 2021-09-30 | −$1.3M | −$225,000 | — | — |
| Q4 2020 | 2020-12-31 | −$808,000 | — | — | — |
| Q3 2020 | 2020-09-30 | −$1.1M | — | — | — |
| Q2 2020 | 2020-06-30 | −$1.1M | — | — | — |
| Q1 2020 | 2020-03-31 | −$768,000 | — | — | −768.00% |
GRI Bio free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$3.7M to −$10.2M, a net decrease of $6.5M. GRI Bio's latest reported quarter, Q3 2024, generated −$2.3M in free cash flow, a decrease of $957,000 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review GRI Bio source filings ↗